-
Weekly Pharma News Review | PharmaSources.com (0919-0923)
Industry Data
PharmaSources.com
September 26, 2022
The news reviewed this week is from September 19 to 23, covering a total of 25 pieces of information in 4 sections, i.e. drug review, R&D, and business and listing.
-
Weekly Pharma News Review | PharmaSources.com (0912-0916)
Industry Data
PharmaSources.com
September 20, 2022
The news reviewed this week is from September 12 to 16, covering a total of 26 pieces of information in 3 sections, i.e., drug review, R&D, and business.
-
Weekly Pharma News Review | PharmaSources.com (0905-0909)
Industry Data
PharmaSources.com
September 14, 2022
The news review of this week is from September 5 to 9, covering a total of 25 pieces of information in 3 sections, i.e., drug review, R&D, and business.
-
Weekly Pharma News Review | PharmaSources.com (0829-0902)
Industry Data
PharmaSources.com
September 06, 2022
This week, the second biological drug developed by SinoCellTech - ripertamab, a new anti-CD20 monoclonal antibody, was approved for marketing, which aroused the attention of the industry. The news review of this week is from August 29 to September 2.
-
Weekly Pharma News Review | PharmaSources.com (0822-0826)
Industry Data
PharmaSources.com
August 29, 2022
The EU officially released the eagerly anticipated final revision of its GMP Annex 1 for sterile drug products. The news review of this week is from August 22 to 26, covering a total of 20 pieces of information on drug review, R&D, business, and policy.
-
Weekly Pharma News Review | PharmaSources.com (0815-0819)
Industry Data
PharmaSources.com
August 23, 2022
Alphamab Oncology’s JSKN003 injection became the first Chinese bispecific antibody ADC declared for clinical use. The news review of this week is from August 15 to 19, covering a total of 24 pieces of information on drug review, R&D, and business.
-
Weekly Pharma News Review | PharmaSources.com (0808-0812)
Industry Data
PharmaSources.com
August 17, 2022
The FDA approved the supplementary new drug application for Bayer’s darolutamide in combination with docetaxel, which sparked widespread social attention. The news review of this week is from August 8 to 12, covering a total of 23 pieces of information.
-
Quality Sourcing Opportunities at 2022 Zhejiang Export Commodity Online Fair “Thailand & Indonesia - Natural Extracts Session”!
Products Guide
PharmaSources.com
June 17, 2022
The 2022 Zhejiang Export Commodity Online Fair (Pharma Sector) is coming with a new session. The portals for the “Thailand & Indonesia - Natural Extracts Session” is now launched to welcome the participation of both pharmaceutical suppliers ...
-
CPHI China opens for international partnering after China rises in CPHI Index
Market news
PharmaSources.com
June 08, 2022
CPHI & P-MEC China opens its online international partnering platform as pharmaceutical and biopharmaceutical industries in the country report strong underlying conditions and see increases in all categories of the most recent CPHI Pharma Index.
-
Pharma Sources Insight June 2022: New Developments of COVID-19, Greater Impact on the Pharma Market
Features
Pharma Sources Insight
May 22, 2022
Pharma Sources Insight June 2022 focuses on new developments of COVID-19, and greater impacts it brings to the Pharma Market.
Pharma Sources Insight JUNE2022
